NPPB and pulmonary fibrosis: In their study, a significant reduction in GLS (i.e., ≥15%) was found in 19% of cases, and these patients were more likely to have proximal muscle weakness, lung fibrosis, renal impairment and elevated NTproBNP at follow-up, alongside a higher risk of all-cause mortality [26].